Home > Riviste > Minerva Medica > Fascicoli precedenti > Minerva Medica 2016 February;107(1) > Minerva Medica 2016 February;107(1):62-9

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Estratti
Per citare questo articolo

 

REVIEWS   

Minerva Medica 2016 February;107(1):62-9

Copyright © 2016 EDIZIONI MINERVA MEDICA

lingua: Inglese

Meta-analysis of diagnostic value of serum Carbohydrate antigen 199 in pancreatic cancer

Yun ZHANG 1, Lihua JIANG 2, Lin SONG 1

1 Department of Oncology, Linyi Peopales’ Hospital, Linyi, China; 2 Department of Oncology, The Third Peoples’ Hospital of Linyi, Linyi, China


PDF


INTRODUCTION: Carbohydrate antigen 199 (CA199) has been used as a new promising serum biomarker for the diagnosis of pancreatic cancer. But its utility was full of controversies. This study sought to determine the diagnosis value of serum CA199 in pancreatic cancer through enrolling all the related eligible studies.
EVIDENCE ACQUISITION: We searched PubMed, Medline, Embase, ISI databases to collect articles in English that evaluated the diagnostic value of CA199 in patients with pancreatic cancer. Two reviewers independently assessed the methodological quality of each study using the quality assessment of diagnostic accuracy studies tool. The data were analyzed using Meta-Disc (Version 1.4) and Stata (Version 12.0) software. We estimated the sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR) and summary receiver operating characteristic (SROC). A total of 11 studies involving 2,316 individuals were included.
EVIDENCE SYNTHESIS: The pooled sensitivity and specificity for CA199 in diagnosing pancreatic cancer were 0.80 (95% confidence interval [CI], 0.77-0.82) and 0.80 (95% CI: 0.77-0.82), respectively. The DOR was 14.79 (95% CI: 8.55-25.59) and the area under the SROC curve was 0.87.
CONCLUSIONS: The current analyses indicated that CA199 is a valuable marker in the diagnosis of pancreatic cancer.

inizio pagina